BUZZ-Freshworks stock rises ahead of inclusion in S&P SmallCap 600 Index
路透社2026/10/06 08:36October 6 — Software development company Freshworks Inc (FRSH.O) saw its shares rise by 4.3% to $13.79 in pre-market trading. The company will replace BioLife Solutions (BLFS.O) in the S&P SmallCap 600 Index, effective before market open on October 8, according to an announcement released after the U.S. stock market closed on Monday. BLFS is set to be acquired later this year by Repligen Corp (RGEN.O), pending regulatory and shareholder approval. According to data from London Stock Exchange Group (LSEG), as of the previous trading session's close, FRSH had a market value of $3.45 billions. As of the last close, the stock had gained 7.9% so far this year. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. Because automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translations and provides them for the convenience of readers only. Reuters assumes no responsibility for any damage or loss resulting from the use of automated translation features.)
October 6 - ** Software development company Freshworks Inc (FRSH.O) rose 4.3% to $13.79 in pre-market trading
** The company will replace BioLife Solutions (BLFS.O) in the S&P SmallCap 600 Index, effective before the market opens on October 8—this was announced after the US market closed on Monday
** BLFS (link) will be acquired later this year by Repligen Corp RGEN.O, a transaction still subject to regulatory and shareholder approval
** According to data from London Stock Exchange Group (LSEG), as of the previous trading session close, FRSH had a market capitalization of $3.45 billion
** As of the last close, the stock is up 7.9% year-to-date
(To assist non-native English speakers, Reuters has automatically translated its reports into several other languages. As automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text, which is provided solely for reader convenience. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Are US Real Estate Stocks Dead? What the Charts and Rates Show
Hypertension drug developer Retension (RTSN.US) IPO priced at $11-13 per share, aiming to raise $40 million.
Retension Pharmaceuticals (RTSN.US) announced the terms of its initial public offering (IPO) on Monday.
Australian Dollar: Oversold conditions limit losses against US Dollar – UOB
Who will win? A bond storm sweeps through the US, Europe, and Japan, while global stock markets approach record highs
US Treasury yields have reached a peak of 5.31%, the highest since 2002, and European bond markets have fallen to multi-decade lows. Despite this global bond market turmoil, equities remain unfazed: the S&P 500 is approaching its historical high, with all of the “Magnificent Seven” tech stocks advancing, and the STOXX 600 index in Europe touched a new intraday record. Earnings growth, rather than valuation expansion, has become the core support for equities, while the ongoing wave of AI capital expenditure continues to attract funds. However, Ray Dalio has warned that the US debt cycle is nearing its limit, raising questions about how much further this divergence between stocks and bonds can continue.
Crypto prices
More
